WHAT DOES INTEGRATION LOOK LIKE?
Global reach with local knowledge.
Given the interdependencies between each stage in cell and gene therapy, bespoke and integrated supply chain elements are essential. The supply chain for these innovative, often curative therapies is complicated from the outset and calls for a qualified logistics partner to help innovators manage these critical intricacies.
No Room for Error
The Interdependent Supply Chain
The Supply Chain Redefined:
The right partner will offer data integration capabilities that will allow for effective communications between all stakeholders involved in the process and (at a minimum) enable the supply chain to be choreographed.
Innovation for a new frontier.
Consider the “cost” of cell and gene products for the patient—there is no backup vial that can be overnighted because this is their own material. The right logistics partner knows one missed delivery can mean a patient’s life and will set a high bar for the patient-centered supply chain that cell and gene therapies demand.
CELL AND GENE THERAPIES
Logistics partners who use data to complement their local knowledge—including customs and regulatory requirements—can give manufacturers greater confidence about product safety with sophisticated route planning and packaging choices.
Much of the complexity of the cell and gene supply chain comes from how dependent the commercialization phase is on the clinical phase. More than ever, manufacturers must work with providers to develop a logistics platform that will connect patients with their therapies — throughout the development lifecycle.
Partners who can offer a global network, operating on quality processes, with employees trained to the same standards worldwide, are well-placed for support as the scaled-out supply chain crosses international boundaries, time zones and climates. Local knowledge of customs and regulatory requirements is equally critical to streamlining an already complex journey.
Data that acts as a communication driver.
As momentum builds around cell and gene therapies, it will drive innovations beyond the therapies themselves. For example, the specific combination of size and temperature requirements for cell and gene therapies can be expected to drive packaging that more efficiently meet these needs.